SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as it gears up for a highly anticipated oral presentation of its pancreatic cancer data at the upcoming Digestive Disease Week conference. The community is buzzing with optimism, pointing to a recent string of clinical catalysts and trial expansions as key drivers for potential upward momentum.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

The RETIRE token is trending as the community rallies around its identity as a 'tokenized retirement fund' designed to replace traditional systems. Investors are actively discussing its potential for life-changing gains while highlighting features like locked liquidity and a dedicated movement to achieve early financial independence.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and community speculation driven by its technical breakout attempts and active rotation into IoT, AI, and Japanese blockchain sector narratives. Traders remain sharply divided, with bulls pointing to ecosystem expansion and accumulation as the foundation for a potential run, while skeptics warn of volatility and continue to debate the project's long-term utility.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll is capturing significant market attention as traders rotate into established, meme-driven small caps, with the community actively rallying around its legacy as an original internet meme. Investors are highlighting the asset's cultural durability and momentum, frequently discussing it alongside other high-beta tokens as part of a broader shift in retail liquidity.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector is experiencing extreme volatility as investors rotate out of extended, AI-driven positions following record-breaking capital inflows. The market is debating whether this pullback represents a healthy cooldown for the broader AI infrastructure demand or the beginning of a larger structural rotation as sentiment shifts from blind optimism to risk management.

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).   The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.  The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

Bio Protocol

Bio Protocol is experiencing significant momentum driven by its recent listing on Coinbase, fueling community speculation about a potential breakout toward higher price levels. Investors are actively discussing the project's scalability, DeSci potential, and technical chart patterns while debating whether current volume levels signal a sustained rally or a temporary pump.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is trending as institutional interest remains high, highlighted by BlackRock's filing for tokenized money-market funds on the network and Bitmine's aggressive treasury acquisitions. While some community members are cautious due to cooling momentum and reduced long exposure in derivatives, many long-term holders view current price consolidation as a strategic accumulation phase.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network is attracting attention as the community bets on its pivot toward privacy-focused AI solutions and potential integration within broader web3 infrastructure. Investors are actively discussing its long-term utility and low market capitalization while speculating on a breakout as interest in privacy-centric sectors gains momentum.

$LADYS coin has no association with Charlotte Fang or her creation Milady Maker. This token is simply paying homage to a meme we all love and recognize.  $LADYS is a meme coin with no intrinsic value or expectation of financial return. There is no formal team or roadmap. the coin is completely useless and for entertainment purposes only.  The project was initiated on 05 May 2023 and the contract was deployed on 07 May 2023.  The project will be launching a dapp on the official website for all holders of PEPE tokens and Milady Maker NFTs to claim $LADYS.

Milady

Milady is trending as the community actively discusses high-growth potential and hopes for a major exchange listing, despite debates over price stagnation and scam accusations. Investors are closely monitoring volume and price action, with many using the "IYKYKWAGMITRUSTMEBRO" sentiment to coordinate social media hype and encourage DCA strategies in anticipation of an altcoin market breakout.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining momentum as investors anticipate a potential breakout driven by strong commercial performance, upcoming clinical data, and long-standing buyout rumors. The community is actively discussing the company's trajectory toward blockbuster revenue status and the strategic impact of recent pipeline advancements, leading many to hold shares in anticipation of further price appreciation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HRMY or ARGX: Which Is the Better Value Stock Right Now?

HRMY vs. ARGX: Which Stock Is the Better Value Option?

Jennison Associates LLC Reduces Stock Position in argenex SE $ARGX

Jennison Associates LLC cut its stake in argenex SE (NASDAQ:ARGX - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange...

argenex (ARGX) to Release Earnings on Thursday

argenex (NASDAQ:ARGX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-argenx-se-stock...

Pictet Asset Management Holding SA Sells 16,122 Shares of argenex SE $ARGX

Pictet Asset Management Holding SA cut its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 9.5% during the 4th quarter, according to the company in its most recent disclosure with the...

argenex SE $ARGX Shares Bought by Evergreen Capital Management LLC

Evergreen Capital Management LLC raised its position in argenex SE (NASDAQ:ARGX - Free Report) by 452.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,907 shares of the company's stock after purc...

Mirae Asset Global Investments Co. Ltd. Buys 2,018 Shares of argenex SE $ARGX

Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 22.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,846 shares of the company's stock after purchasing an additional 2...

argenex SE (NASDAQ:ARGX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of argenex SE (NASDAQ:ARGX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the twenty-four brokerages that are covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation, eighteen have given a buy recommenda...

Sivik Global Healthcare LLC Purchases Shares of 1,500 argenex SE $ARGX

Sivik Global Healthcare LLC purchased a new stake in argenex SE (NASDAQ:ARGX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm...

argenex SE $ARGX Shares Sold by Aberdeen Group plc

Aberdeen Group plc lowered its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 21.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 52,347...

Perpetual Ltd Cuts Stock Position in argenex SE $ARGX

Perpetual Ltd trimmed its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 37.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and...

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Argen X SE - ADR

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

ARGX
Argenx

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARGX News

ARGXArgenx